NCT01834703 is a NA clinical trial of UAE in Uterine Fibroids, sponsored by Chinese University of Hong Kong.

Who is sponsoring NCT01834703?

NCT01834703 is sponsored by Chinese University of Hong Kong.

What drugs are being tested in NCT01834703?

Interventions in NCT01834703: UAE, HIFU.

What condition does NCT01834703 study?

NCT01834703 studies Uterine Fibroids.

Is NCT01834703 still recruiting?

NCT01834703 is currently terminated. Last updated 28 August 2019.

Last reviewed 2019-08-28 · How we verify

NCT01834703

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Randomized Controlled Trial of Uterine Artery Embolization (UAE) Versus High-Intensity-Focused-Ultrasound (HIFU) for Treatment of Patients With Uterine Fibroids

Terminated NA Last updated 28 August 2019

What this trial tests

NA trial testing UAE in Uterine Fibroids in 85 participants. Terminated before completion.

Timeline

1 May 2009

Primary endpoint
1 December 2015

1 December 2015

Quick facts

Lead sponsor	Chinese University of Hong Kong
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	85
Start date	1 May 2009
Primary completion	1 December 2015
Estimated completion	1 December 2015
Sites	2 locations across Hong Kong

Drugs / interventions tested

UAE
HIFU

Conditions studied

Uterine Fibroids — all drugs for Uterine Fibroids →

Sponsor

Chinese University of Hong Kong

Who can join

Adults 30 to 47, female only, with Uterine Fibroids. Patients with the condition only — healthy volunteers not accepted.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Treatment success rate
Time frame: 6 months
Technical success of treatment procedure and absence of symptoms of fibroid

Sponsor's own description

This study aimed to evaluate the clinical effectiveness and adverse effects of Uterine Artery Embolization (UAE), High-Intensity-Focused-Ultrasound (HIFU) in treating patients with uterine fibroid.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of UAE

Trials testing the same drug.

NCT06719934 — Ttt of Adenomyosis · Phase 1 · not yet recruiting

Other recruiting trials for Uterine Fibroids

Currently open trials in the same condition.

NCT07378098 — to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and Menorrhagia · Phase 3 · recruiting
NCT07486622 — Transvaginal Electromechanical Fragmentation and Removal of Large Uterus in a Sealed Bag: The First Group of Clinical St · active not recruiting
NCT06671548 — Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine Fibroids · Phase 3 · recruiting
NCT05448365 — Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid · NA · recruiting
NCT04126824 — Effect of Addition of Steroids on Duration of Analgesia · EARLY_PHASE1 · active not recruiting

Other Chinese University of Hong Kong trials

Trials by the same sponsor.

NCT07508644 — RSV Vaccination to Reduce Recurrent AECOPD · Phase 4 · not yet recruiting
NCT07230457 — Plasma MTB cfDNA Before Bronchoscopy · not yet recruiting
NCT07288671 — Nostalgia Intervention on Alleviating Loneliness Amongst Older Adults · NA · not yet recruiting
NCT07256457 — Postoperative Pulmonary Function Assessment Based on Deep Learning Study · NA · not yet recruiting
NCT06904209 — Can Artificial Intelligence Reduce Consumption of Standard High Volume Bowel Preparation Regimen Among Older Population, · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT01834703 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Chinese University of Hong Kong
Last refreshed: 28 August 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01834703.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing